Neuralink has 6 close competitors: Abridge, Alloy Therapeutics, HistoSonics.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
NeuralinkAbridgeZocdocBenchlingCommureNeuralink Corp. is an American neurotechnology company developing implantable brain-computer interfaces. Founded in 2016 by Elon Musk and a team of eight scientists and engineers, it is based in Fremont, California, and implanted its first device in a human in January 2024. Its products are branded Telepathy and Blindsight.
Neuralink competes with 6 companies here: Abridge, Alloy Therapeutics, HistoSonics, Zocdoc, Benchling, Commure.
Neuralink was last valued at $9B (post-money, Jun 2025). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. Neuralink is a private company; its shares do not trade on a public exchange.
The last valuation is $9B (post-money, Jun 2025).
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
